Berg LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Berg LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10580
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Berg LLC (Berg) is a biopharmaceutical company that focus on therapeutic discovery using AI-based Interrogative biology platform. The company’s proprietary platform Interrogative Biology, combines patient biology and artificial intelligence-based analytics to understand predictive patterns on diseases. Its pipeline products include BPM 31510 and BPM 31543. Berg’s platform identifies therapies and biomarkers by applying algorithm and probability-based artificial intelligence to analyze large numbers of patient’s genotypic, phenotypic, and other characteristics. The company carries out research and development of diagnostics, theranostics and patient therapeutics in the areas of oncology, endocrinology and neurology. Its analytics engine enables health plans, EHR vendors, providers, and clinical decision support organizations to plan, implement and measure interventions. Berg is headquartered in Framingham, Massachusetts, the US.

Berg LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Berg LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Berg LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Berg LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Berg LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Berg LLC, Medical Devices Deals, 2012 to YTD 2018 9
Berg LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Berg LLC, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
BERG, Massachusetts General Hospital and Brigham and Women’s Hospital Enter into Research Agreement 11
Berg Enters into Research Agreement with Sanofi 12
BERG Enters into Research Partnership with AstraZeneca 13
BERG Enters into Research Agreement with Department of Defense and Walter Reed National Military Medical Center 14
BERG Partners with Parkinson’s Institute and Clinical Center 15
Berg To Enter Into Agreement With Medical University Of South Carolina For Lupus Biomarker Discovery 16
Berg Enters Into Drug Discovery And Development Agreement With Icahn School Of Medicine 17
Berg Pharma Enters Into R&D Agreement with U.S. Department of Defense For Prostate Cancer Biomarker Discovery 18
Berg Pharma Enters Into Co-Development Agreement With Parkinson’s Institute 19
Berg LLC – Key Competitors 20
Berg LLC – Key Employees 21
Berg LLC – Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Corporate Communications 23
Feb 07, 2017: BERG Announces Appointment of Titus Plattel as Chief Operating Officer 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Berg LLC, Pharmaceuticals & Healthcare, Key Facts 2
Berg LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Berg LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Berg LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Berg LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Berg LLC, Medical Devices Deals, 2012 to YTD 2018 9
Berg LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BERG, Massachusetts General Hospital and Brigham and Women’s Hospital Enter into Research Agreement 11
Berg Enters into Research Agreement with Sanofi 12
BERG Enters into Research Partnership with AstraZeneca 13
BERG Enters into Research Agreement with Department of Defense and Walter Reed National Military Medical Center 14
BERG Partners with Parkinson's Institute and Clinical Center 15
Berg To Enter Into Agreement With Medical University Of South Carolina For Lupus Biomarker Discovery 16
Berg Enters Into Drug Discovery And Development Agreement With Icahn School Of Medicine 17
Berg Pharma Enters Into R&D Agreement with U.S. Department of Defense For Prostate Cancer Biomarker Discovery 18
Berg Pharma Enters Into Co-Development Agreement With Parkinson's Institute 19
Berg LLC, Key Competitors 20
Berg LLC, Key Employees 21

List of Figures
Berg LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Berg LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Berg LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Berg LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Berg LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Berg LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Berg LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Berg LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Berg LLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Berg LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • LBT Innovations Limited (LBT):製品パイプライン分析
    Summary LBT Innovations Limited (LBT) is a medical device company that designs, develops and commercializes various products and automation technologies for the preparation and analysis of microbiology culture specimens, and microbiology and diagnostic laboratory services. It offers MicroStreak tech …
  • Lockheed Martin Corporation:企業のM&A・事業提携・投資動向
    Lockheed Martin Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lockheed Martin Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Guardant Health Inc (GH):医療機器:M&Aディール及び事業提携情報
    Summary Guardant Health Inc (Guardant Health) is a non-invasive cancer diagnostics company that commercializes genomic liquid biopsy. The company develops proprietary digital sequencing technology used to detect individual genomic alterations. It offers Guardant360, a tool for early cancer detection …
  • CytoSorbents Corp (CTSO):医療機器:M&Aディール及び事業提携情報
    Summary CytoSorbents Corp (CytoSorbents), formerly MedaSorb Technologies Corp, is a critical care immunotherapy company that develops blood purification products. Its flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed to control extreme systemic inflammation in seriou …
  • Ambry Genetics Corp:医療機器:M&Aディール及び事業提携情報
    Summary Ambry Genetics Corp (Ambry Genetics), a subsidiary of Konica Minolta Inc, is a provider of clinical genetic testing services. The company provides genetic diagnosis for various conditions including hereditary cancer, epilepsy, hereditary cardiovascular disease and neurodevelopmental disorder …
  • Lysogene SAS (LYS):製薬・医療:M&Aディール及び事業提携情報
    Summary Lysogene SAS (Lysogene) is a clinical research center that offers basic research and clinical development programs. The center offers clinical development of gene therapy for neurodegenerative disorders such as Parkinson and Alzheimer diseases. It also develops models in gene therapy trials …
  • Cynvenio Biosystems Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Cynvenio Biosystems Inc (Cynvenio) is a cancer diagnostic company that focuses on transforming cancer treatment and management through the molecular analysis of cancer biomarkers in blood. The company offers products such as lab automation systems, isolation products and proprietary informat …
  • Taneja Aerospace & Aviation Ltd.
    Taneja Aerospace & Aviation Ltd. - Strategy, SWOT and Corporate Finance Report Summary Taneja Aerospace & Aviation Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Croda International Plc (CRDA):企業の財務・戦略的SWOT分析
    Croda International Plc (CRDA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Compagnie Des Alpes Sa
    Compagnie Des Alpes Sa - Strategy, SWOT and Corporate Finance Report Summary Compagnie Des Alpes Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Avidity Biosciences LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Avidity Biosciences LLC (Avidity Biosciences), formerly Avidity NanoMedicines LLC is a biotech company that develops antibody oligonucleotide conjugates (AOCs). The company’s proprietary platform technology has enhanced pharmacokinetic and biodistribution properties that improves the deliver …
  • Blue Cross and Blue Shield Association:企業の戦略的SWOT分析
    Blue Cross and Blue Shield Association - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Berthold Technologies GmbH & Co. KG:企業の戦略的SWOT分析
    Berthold Technologies GmbH & Co. KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Acumen Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Acumen Pharmaceuticals Inc (Acumen) is a pharmaceutical company that discovers and develops therapeutics and diagnostics services for the treatment of Alzheimer’s disease and other related neurodegenerative conditions. It focuses on development of ADDL (amyloid-beta derived diffusible ligand …
  • WEG SA:戦略・SWOT・企業財務分析
    WEG SA - Strategy, SWOT and Corporate Finance Report Summary WEG SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Strongbridge Biopharma plc (SBBP):企業の財務・戦略的SWOT分析
    Summary Strongbridge Biopharma plc (Strongbridge) formerly Cortendo Plc, is a commercial-stage biopharmaceutical company that develops and commercializes therapies for rare diseases. The company’s marketed product KEVEYIS (dichlorphenamide) is indicated for the treatment of hypokalemic, hyperkalemic …
  • London North West Healthcare NHS Trust:企業の戦略的SWOT分析
    London North West Healthcare NHS Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Shields Bag And Printing Company
    Shields Bag And Printing Company - Strategy, SWOT and Corporate Finance Report Summary Shields Bag And Printing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Black Box Corp:企業の戦略的SWOT分析
    Black Box Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Statoil ASA (STL)-エネルギー分野:企業M&A・提携分析
    Summary Statoil ASA (Statoil) is an independent upstream oil and gas company. The company explores for, develops and produces oil and gas from its assets across the world, and trades crude oil and natural gas. The company operates assets in Norwegian Continental Shelf (NCS), which includes the North …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆